載入...
Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study
BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...
Na minha lista:
| 發表在: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley Periodicals, Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/ https://ncbi.nlm.nih.gov/pubmed/30443921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|